Miloš Grujić: Highlighting the dangers of inappropriate prescribing in prostate cancer patients
Miloš Grujić, Head of Department of the subspecialist cabinets at the Center for Radiation Oncology at the University Clinical Center Kragujevac, posted on LinkedIn, about recent paper by Marija Peulic et al., titled “Factors Associated with Potentially Inappropriate Prescribing in Patients with Prostate Cancer” published on Journal of Clinical Medicine.
Authors: Marija Peulic, Radica Zivkovic Zaric, Milorad Stojadinovic, Miodrag Peulic, Jagoda Gavrilovic, Marija Zivkovic Radojevic, Milos Grujic, Marina Petronijevic, Vladan Mutavdzic, Ognjen Zivkovic, Nevena Randjelovic, Neda Milosavljevic
“I am thrilled to share that I have co-authored the recently published article, ‘Factors Associated with Potentially Inappropriate Prescribing in Patients with Prostate Cancer,’ in the Journal of Clinical Medicine.
This study highlights the dangers of inappropriate prescribing in prostate cancer patients, especially in older men with multiple comorbidities. It stresses the importance of personalized prescribing to enhance patient outcomes and cut healthcare expenses.
Key discoveries from the research include:
- The correlation between elevated PSA levels, intermittent androgen deprivation therapy (ADT), and polypharmacy with inappropriate prescriptions.
- The crucial role of healthcare providers in implementing tools and tactics to mitigate these risks.
I am thankful to have collaborated with a remarkable team of researchers and to have played a part in such a significant undertaking. Kudos to the lead authors and the entire team for their commitment and effort!
For those interested in delving deeper.
I welcome your thoughts and insights on this subject – let’s unite to enhance care for prostate cancer patients!”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023